Article

Cost Implications of Pertuzumab/Trastuzumab Combination

In this segment, panelists address coverage strategies health plans may utilize to finance patient access to the combination treatment.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
John Barkett, MBA
John Barkett, MBA
John Barkett, MBA
Tom Belmont
Dr Mingyang Song
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo